Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Outstanding shares
Dutton report says the number is 384 million as of 11/30/06 balance sheet date. As of January 12 the number was 381 million. Since then they have repurchased at least 2 million.
Share
New Message
Please login to post a reply